Therapeutic lung lavages in children and adults

被引:28
作者
Paschen, C
Reiter, K
Stanzel, F
Teschler, H
Griese, M
机构
[1] Univ Munich, Dr von Haunersches Kinderspital, D-80337 Munich, Germany
[2] ASKLEPIOS Fachkliniken, Zentrum Pneumol & Thoraxchirurg, D-82131 Munich, Germany
[3] Univ Essen Gesamthsch, Dept Resp & Sleep Med, Ruhrlandklin, Essen, Germany
关键词
D O I
10.1186/1465-9921-6-138
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary alveolar proteinosis ( PAP) is a rare disease, characterized by excessive intra-alveolar accumulation of surfactant lipids and proteins. Therapeutic whole lung lavages are currently the principle therapeutic option in adults. Not much is known on the kinetics of the wash out process, especially in children. Methods: In 4 pediatric and 6 adult PAP patients 45 therapeutic half lung lavages were investigated retrospectively. Total protein, protein concentration and, in one child with a surfactant protein C mutation, aberrant pro-SP-C protein, were determined during wash out. Results: The removal of protein from the lungs followed an exponential decline and averaged for adult patients 2 - 20 g and < 0.5 to 6 g for pediatric patients. The average protein concentration of consecutive portions was the same in all patient groups, however was elevated in pediatric patients when expressed per body weight. The amount of an aberrant pro-SP-C protein, which was present in one patient with a SP-C mutation, constantly decreased with ongoing lavage. Measuring the optical density of the lavage fluid obtained allowed to monitor the wash out process during the lavages at the bedside and to determine the termination of the lavage procedure at normal protein concentration. Conclusion: Following therapeutic half lung lavages by biochemical variables may help to estimate the degree of alveolar filling with proteinaceous material and to improve the efficiency of the wash out, especially in children.
引用
收藏
页数:10
相关论文
共 40 条
  • [1] AN ANTIBODY WITH SPECIFICITY FOR SURFACTANT PROTEIN-C PRECURSORS - IDENTIFICATION OF PRO-SP-C IN RAT LUNG
    BEERS, MF
    WALI, A
    ECKENHOFF, MF
    FEINSTEIN, SI
    FISHER, JH
    FISHER, AB
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1992, 7 (04) : 368 - 378
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene
    Brasch, F
    Griese, M
    Tredano, M
    Johnen, G
    Ochs, M
    Rieger, C
    Mulugeta, S
    Müller, KM
    Bahuau, M
    Beers, MF
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (01) : 30 - 39
  • [4] PULMONARY ALVEOLAR PROTEINOSIS - INCLUDING PULMONARY ELECTRON MICROSCOPY
    DANIGELIS, JA
    MARKARIAN, B
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1969, 118 (06): : 871 - +
  • [5] Congenital alveolar proteinosis in the Netherlands: A report of five cases with immunohistochemical and genetic studies on surfactant apoproteins
    delaFuente, AA
    Voorhout, WF
    deMello, DE
    [J]. PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1997, 17 (02): : 221 - 231
  • [6] Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression
    Dirksen, U
    Nishinakamura, R
    Groneck, P
    Hattenhorst, U
    Nogee, L
    Murray, R
    Burdach, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) : 2211 - 2217
  • [7] Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis
    Doyle, IR
    Davidson, KG
    Barr, HA
    Nicholas, TE
    Payne, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (02) : 658 - 664
  • [8] AUTOIMMUNITY IN CHILDHOOD PULMONARY ALVEOLAR PROTEINOSIS
    GRAY, ES
    [J]. BRITISH MEDICAL JOURNAL, 1973, 4 (5887) : 296 - 297
  • [9] Airway inflammation in children with tracheostomy
    Griese, M
    Felber, J
    Reiter, K
    Strong, P
    Reid, K
    Belohradsky, BH
    Jäger, G
    Nicolai, T
    [J]. PEDIATRIC PULMONOLOGY, 2004, 37 (04) : 356 - 361
  • [10] Gunther A, 1996, AM J RESP CRIT CARE, V153, P176